Nutriflex Omega 56/144/40

Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonine, the active ingredient in Nutriflex Omega 56/144/40, is an amino acid solution presented as an intravenous solution for intravenous use. It supplies essential and non‑essential amino acids to support protein synthesis and metabolic needs during parenteral nutrition for patients who cannot receive enteral feeding. GNH USA supplies Nutriflex Omega 56/144/40 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Nutriflex Omega 56/144/40 is used in parenteral nutrition to provide a balanced amino acid profile for patients with compromised oral or enteral intake. - Patients unable to receive enteral feeding: delivers a complete set of amino acids to maintain nitrogen balance. - Surgical and trauma patients: supports protein synthesis and wound healing during the peri‑operative period. - Critically ill or intensive‑care patients: helps preserve lean body mass and metabolic stability. - Neonates and infants requiring parenteral nutrition: supplies essential amino acids for growth and development.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels during infusion. - Electrolyte disturbances: shifts in potassium, sodium, or calcium. - Infusion site reactions: erythema, pain, or phlebitis. - Mild fever or chills during administration. - Nausea or vomiting related to metabolic changes. - Metabolic alkalosis: increased blood pH.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergy requiring immediate intervention. - Severe hypernatremia: dangerously high sodium concentration. - Hepatic dysfunction: abnormal liver enzyme elevations. - Metabolic acidosis: low blood pH in susceptible patients. - Thrombophlebitis: clot formation at the catheter site. - Acute renal failure: sudden loss of kidney function in high‑risk individuals.

Nutriflex Omega 56/144/40 should be used with careful clinical monitoring. - Renal function: assess creatinine clearance before and during therapy. - Electrolyte monitoring: check serum electrolytes regularly. - Blood glucose: monitor glucose levels, especially in diabetic patients. - Compatibility: avoid mixing with calcium‑containing solutions to prevent precipitation. - Aseptic technique: ensure sterile handling to reduce infection risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Nutriflex Omega 56/144/40 may interact with other intravenous agents. Major Interactions (Avoid): - Calcium‑containing solutions: risk of precipitation and catheter blockage. - High‑dose vitamin C: oxidative degradation of amino acids. - Certain antibiotics (e.g., aminoglycosides): increased nephrotoxicity. - Loop diuretics: amplified electrolyte shifts. - Parenteral lipid emulsions: potential for physical incompatibility.

Moderate Interactions (Monitor Closely): - Insulin therapy: may require glucose monitoring and dose adjustment. - Other amino‑acid solutions: cumulative amino‑acid load. - Anticoagulants: possible alteration of coagulation parameters. - Diuretics: monitor fluid and electrolyte balance. - Renal replacement therapy: adjust dosing based on clearance.